Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Authors

Sheng Xu (ORCID: https://orcid.org/0000-0003-0757-8289)
Nicole Lamanna (ORCID: https://orcid.org/0000-0003-3331-9491)
Ayad K. Ali (ORCID: https://orcid.org/0000-0003-4665-5769)
P. Rakonczai
Wassim Aldairy
Nicolás Martínez‐Calle (ORCID: https://orcid.org/0000-0002-5184-9464)
Rhys Williams (ORCID: https://orcid.org/0000-0003-0840-9292)
Talha Munir (ORCID: https://orcid.org/0000-0002-2901-0769)
Balázs Dobi (ORCID: https://orcid.org/0000-0002-1187-4104)
Leyla Mohseninejad
Xiaoyun Ge (ORCID: https://orcid.org/0000-0002-4605-101X)
Keri Yang
Han Ma (ORCID: https://orcid.org/0000-0001-9985-3035)

Institutions

Ithaka Harbors (US)
Leeds Teaching Hospitals NHS Trust (GB)
Columbia University Irving Medical Center (US)
St James's University Hospital (GB)
Universidad San Carlos (PY)
Inholland University of Applied Sciences (NL)

Publication Details

Journal: Oncology and Therapy
Published: 2025-09-13
DOI: https://doi.org/10.1007/s40487-025-00380-0
Primary Topic: Chronic Lymphocytic Leukemia Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Sheng Xu, Nicole Lamanna, Ayad K. Ali, P. Rakonczai et al.

Sep 13, 2025

2 links

Oncology and Therapy

Chronic Lymphocytic Leukemia Research

article

Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Sheng Xu, Nicole Lamanna, Ayad K. Ali, P. Rakonczai, Wassim Aldairy, Nicolás Martínez‐Calle, Rhys Williams, Talha Munir, Balázs Dobi, Leyla Mohseninejad, Xiaoyun Ge, Keri Yang, Han Ma

September 13, 2025article en

Abstract

No abstract available for this paper.

Oncology and TherapyVol. 13(4)

Ithaka Harbors (US), Leeds Teaching Hospitals NHS Trust (GB), Columbia University Irving Medical Center (US), St James's University Hospital (GB), Universidad San Carlos (PY), Inholland University of Applied Sciences (NL)

Openalex Percentile: Top 66%

Chronic Lymphocytic Leukemia Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Sheng Xu, Nicole Lamanna, et al. · Oncology and Therapy (2025) | TGRS Research Map | TGRS